Single-Cell Computational Frameworks for Quantifying BET Bromodomain Inhibitor Resistance and Screening Re-Sensitizer Drugs in Triple-Negative Breast Cancer.

Jyseleca (filgotinib) - Gilead

http://www.ncbi.nlm.nih.gov/pubmed/41933924

Fei Hou; Haizhou Liu; Jiahao Chen; Lihong Wang; Mengqin Yuan; Wei Jiang; Yini Shang

Apr 4, 2026